The Importance of Examining Antinuclear Antibody (Ana) in Neurological Diseases

Basit Öğe Kaydı
dc.authorid0000-0002-9969-4254
dc.authorwosidozen, banu/ABI-8008-2020
dc.contributor.authorBarut, Banu Özen
dc.contributor.authorEmre, Ufuk
dc.contributor.authorDemir, Ayse Semra
dc.contributor.authorÜnal, Aysun
dc.contributor.authorTekin, Ishak
dc.date.accessioned2022-05-11T14:12:17Z
dc.date.available2022-05-11T14:12:17Z
dc.date.issued2013
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Nöroloji Ana Bilim Dalı
dc.departmentFakülteler, Fen Edebiyat Fakültesi, Fizik Bölümü
dc.description.abstractObjective: In neurological clinical practice screening test for ANA (Anti-nuclear antibody) is helpful in the diagnosis of autoimmune diseases which have neurological involvement. ANA investigation tests might be positive both in connective tissue disorders with neurological symptoms, such as Systemic Lupus Erythematosus, Sjogren's disease, Rheumatoid Arthritis and also in neurological diseases in the which autoimmune system is responsible such as Multiple Sclerosis (MS) and Myastenia Gravis. In addition drug usage and older age are the factors which might cause positive results in ANA screening tests. In this study we aimed to investigate the neurological diseases which are associated with postive ANA tests and to understand the efficiency of this screening test in neurological practice. Material and Method: The patients who were followed up in neurology outpatient clinic with positive ANA test were investigated. The medical records of 309 patients with positive ANA results were evaluated. The most common neurological diseases with positive ANA and ANA patterns were determined. Results: The patients who were thought to be demyelinating disease had the highest number of positive ANA results. However, positive ANA results were also found with different and non specific neurological symptoms. Conclusion: As a result of the diagnosis of neurological diseases, positive ANA results might be beneficial in patients with supportive medical history and laboratory findings.
dc.identifier.endpage78
dc.identifier.issn1305-2381
dc.identifier.issue2en_US
dc.identifier.startpage74
dc.identifier.urihttps://hdl.handle.net/20.500.11776/5481
dc.identifier.volume9
dc.identifier.wosWOS:000323802900015
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.institutionauthorÜnal, Aysun
dc.language.isotr
dc.publisherNobel Ilac
dc.relation.ispartofNobel Medicus
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAntinuclear-antibody
dc.subjectdemyelinating disease
dc.subjectautoimmunity
dc.subjectMultiple-Sclerosis
dc.subjectRheumatic-Diseases
dc.subjectAutoantibodies
dc.subjectFrequency
dc.titleThe Importance of Examining Antinuclear Antibody (Ana) in Neurological Diseases
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
5482.pdf
Boyut:
253.2 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Fen Edebiyat Fakültesi Koleksiyonu
Tıp Fakültesi Koleksiyonu